Inmune Bio, Inc. — Director's Dealing 2019

Aug 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2019-08-20

Reporting Person: Tesi Raymond Joseph (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539033	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539133	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539233	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539333	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539433	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539533	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539633	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539733	Direct
2019-08-20	Common Stock	P	100	$5.96	Acquired	1539833	Direct
2019-08-20	Common Stock	P	100	$5.9239	Acquired	1539933	Direct
2019-08-20	Common Stock	P	1000	$6.0308	Acquired	1540933	Direct

Footnotes

F1: The Reporting Person purchased an aggregate of 2,000 shares of the Registrant's common stock on August 20, 2019 in eleven open market transactions.